Biota Pharma (BOTA) Swings to Q2 Loss
Tweet
Share
E-mailGet Alerts BOTA Hot Sheet
Join SI Premium – FREE
Biota Pharma (NASDAQ: BOTA) reported Q2 EPS of ($0.17), versus $0.19 reported last year. Revenue for the quarter came in at $1.7 million, versus $13.9 million reported last year.
For earnings history and earnings-related data on Biota Pharma (BOTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Farmers National Banc (FMNB) Tops Q1 EPS by 1c
- JPM sees risk of further negative earnings revisions for Tesla (TSLA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
